Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
| Product Name | View Product |
|---|---|
| Curosurf Poractant Alfa Injection | View |
SURVANTA INJECTION 8ML belongs to a class of drugs called pulmonary surfactants. It is used in the treatment/prevention of premature infants suffering from or at risk of a condition called respiratory distress syndrome (RDS). Respiratory distress syndrome, or RDS, is caused by insufficient lung surfactant.
SURVANTA INJECTION 8ML contains Beractant, a natural surfactant that acts similarly to the baby's own surfactant, helping your baby to breathe normally. It will help your baby breathe normally until it produces its own surfactant.
SURVANTA INJECTION 8ML will be given to your baby in a hospital by a suitably trained doctor. Sometimes, SURVANTA INJECTION 8ML may cause a slow heart rate, endotracheal tube blockage, and low blood oxygen levels. Talk to the doctor if you have any concerns.
The administration of SURVANTA INJECTION 8ML to your newborn may impair your baby's lungs' ability to absorb oxygen. As a result, your baby will be closely monitored by a nurse or doctor so that oxygen and ventilatory support can be adjusted as needed. If your baby has any problems while being treated with SURVANTA INJECTION 8ML, consult your doctor as soon as possible, even if you do not know the condition is related to the medicine.
Treatment of Respiratory distress syndrome (RDS)
SURVANTA INJECTION 8ML contains Beractant as a natural surfactant. SURVANTA INJECTION 8ML is used to treat respiratory distress syndrome (RDS) in newborn premature infants weighing 700 g or more at delivery. It is also used to treat premature babies who are in danger of developing RDS and require a tube put into their windpipe for stabilisation or who have indications of surfactant deficiency. It functions similarly to your baby's own surfactant, assisting your infant in breathing healthily. It will allow your infant to breathe normally until his or her own surfactant is produced.
SURVANTA INJECTION 8ML will be given to your baby in a hospital by a trained healthcare professional. SURVANTA INJECTION 8ML should be administered via the endotracheopulmonary route. It should only be administered with adequate facilities for ventilation and monitoring babies with RDS (respiratory distress syndrome).
Store in a cool and dry place away from sunlight
Survanta Beractant Intratracheal Suspension Injection 25 mg is a surfactant proven by clinical studies that help prevent and treat Respiratory Distress Syndrome (RDS) in premature infants in the neonatal intensive care setting. The main ingredient in this new surfactant product is beractant that is obtained naturally from bovine lung extract and can lower the surface tension in lungs and make the breathing process more efficient. It is given directly into the lungs by health professionals and is very effective in resuscitating the immature alveoli while at the same time normalizing oxygen levels in newborns suffering from surfactant deficiency.
Being one of the main distributors of Survanta Beractant Intratracheal Suspension Injection 25 mg in India, we strive to provide genuine and best quality pharmaceuticals to the hospitals, clinics, and distributors in different parts of the world. We make sure that through our supply chain all the requirements such as cold storage during handling, secure packaging, and timely delivery are met so that the product efficacy is maintained. Along with offering competitive prices that are in line with international standards, we also make it possible for medical care providers to have easy and reliable access to essential neonatal medicines.
Our primary goal is to create sustainable partnerships by providing products that are always available, meeting all regulatory requirements, and being able to export efficiently worldwide. No matter if it is for the large volume purchase or for the immediate medical needs, our highly competent staff is here to provide uninterrupted assistance and a steady supply of Survanta Beractant Injection throughout the global markets.
Beside this well also export in other countries